Compound information
- Natural Products
- ZC138450
- Molecular Formula
- C21H31N5O6
- Molecular Weight
- 449.227433712 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[2-[[2-[[(1S)-2-[[(1S,2S)-1-carbamoyl-2-methyl-butyl]amino]-1-methyl-2-oxo-ethyl]amino]-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamate
- InChI
- InChI=1S/C21H31N5O6/c1-4-13(2)18(19(22)29)26-20(30)14(3)25-17(28)11-23-16(27)10-24-21(31)32-12-15-8-6-5-7-9-15/h5-9,13-14,18H,4,10-12H2,1-3H3,(H2,22,29)(H,23,27)(H,24,31)(H,25,28)(H,26,30)/t13-,14-,18-/m0/s1
- InChI Key
- NCZGUWKJUIKIAT-DEYYWGMASA-N
- SMILES
- CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)OCc1ccccc1)C(N)=O
- Source
- ZINC000101220199
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 32 | Ring Count | 1 |
Heteroatom Count | 11 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 168.72 Å2 | LogP | 0.614 |
LogS | -2.716 | LogD | 1.253 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.782 |
HIA | 0.009 | F20 % | 0.825 |
F30 % | 0.0 | Caco-2 | -6.321 |
MDCK | -5.686 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.899 | PPB | 81.515 |
VD | 0.459 | Fu | 0.631 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.556 |
CYP2A6 substrate | 0.46 | CYP2B6 substrate | 0.557 |
CYP2C19 inhibitor | 0.134 | CYP2C19 substrate | 0.93 |
CYP2C8 substrate | 0.712 | CYP2C9 inhibitor | 0.001 |
CYP2C9 substrate | 0.973 | CYP2D6 inhibitor | 0.015 |
CYP2D6 substrate | 0.704 | CYP2E1 substrate | 0.259 |
CYP3A4 inhibitor | 0.026 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.817 | CL | 3.565 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.037 | Hepatotoxicity | 0.046 |
Mutagenicity | 0.006 | Rat Oral Acute Toxicity | 0.058 |
FDAMDD | 0.045 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.004 | Eye Corrosion | 0.007 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.025 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.362 | IGC50 | 1.463 |
LC50FM | 1.528 | LC50DM | 2.141 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.164 | NR-AR-LBD | 0.319 |
NR-AhR | 0.002 | NR-Aromatase | 0.039 |
NR-ER | 0.309 | NR-ER-LBD | 0.314 |
NR-PPAR-gamma | 0.278 | SR-ARE | 0.276 |
SR-ATAD5 | 0.344 | SR-HSE | 0.16 |
SR-MMP | 0.01 | SR-p53 | 0.045 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.